SLCO2A1
protein-codingsolute carrier organic anion transporter family member 2A1, the group of Solute carrier organic anion transporter family
Gene summary
This gene encodes a prostaglandin transporter that is a member of the 12-membrane-spanning superfamily of transporters. The encoded protein may be involved in mediating the uptake and clearance of prostaglandins in numerous tissues. [provided by RefSeq, Dec 2011]
- SLC21A2
- MATR1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~119.5 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0008172
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0005265
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013756
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0013756
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0008172
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013756
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0013756
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0018766
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0009799
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013756
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Dermatologic; Gastrointestinal; Musculoskeletal
Intervention: Musculoskeletal
Rationale: For both dominant and recessive forms, medical management (eg, with etoricoxib) has been shown to be clinically beneficial related to manifestations affecting multiple organ systems (eg, joint swelling, skin manifestations)
Comments: Heterozygotes may show mild manifestations
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLCO2A1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005630.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 76 | 7 | 87 | ||
| missense | 10 | 12 | 132 | 22 | 2 | 178 |
| nonsense | 8 | 8 | 1 | 17 | ||
| start loss | 0 | |||||
| frameshift | 11 | 7 | 18 | |||
| splice donor/acceptor (+/-2bp) | 7 | 5 | 4 | 16 | ||
| Total | 36 | 32 | 141 | 98 | 9 | 316 |
Highest pathogenic variant AF is 0.000077012795
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005621.2 | 14 | MANE Select | |
| Ensembl | ENSP00000311291.4 | 14 | MANE Select | |
| Ensembl | ENSP00000420028.3 | 9 | Standard | |
| Ensembl | ENSP00000418893.1 | 13 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Transport of vitamins, nucleosides, and related molecules
- SLC-mediated transmembrane transport
- Transport of small molecules
- Prostaglandin formation from arachidonate
- Transport of organic anions
Biological Process
- lipid transport
- prostaglandin transport
- sodium-independent organic anion transport
- transmembrane transport
Molecular Function
- lipid transporter activity
- prostaglandin transmembrane transporter activity
- sodium-independent organic anion transmembrane transporter activity
Cellular Component
- plasma membrane
- integral component of plasma membrane
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000310926
- Coding exons
- 14
- Length
- 119489
- Individuals with no LoFs
- 125675
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 73
- Defined
- 125748
- p
- 0.000290
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.518 | 339 | 367 | 0.924 | 0.0000202 | 4138 |
| Missense (PolyPhen) | 147 | 164.69 | 0.89257 | 1884 | ||
| Synonymous | 1.08 | 136 | 153 | 0.889 | 0.00000886 | 1322 |
| Loss of Function | 1.32 | 24 | 32.1 | 0.749 | 0.00000177 | 339 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0012 | 0.0012 | notable |
| Latino/Admixed American | 0.000087 | 0.000087 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0.00098 | 0.00098 | rare |
| Finnish | 0.000092 | 0.000092 | rare |
| European (Non-Finnish) | 0.00020 | 0.00020 | rare |
| South Asian | 0.00017 | 0.00016 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May mediate the release of newly synthesized prostaglandins from cells, the transepithelial transport of prostaglandins, and the clearance of prostaglandins from the circulation. Transports PGD2, as well as PGE1, PGE2 and PGF2A.;
Recessive Scores
- pRec
- 0.176
Intolerance Scores
- LoFtool
- 0.891
- RVIS EVS
- 0.27
- RVIS percentile EVS
- 70.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.181
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |